Search

The article discusses a report published in the "Journal of Urology," about a novel classification system developed by experts to characterize subtypes of Peyronie disease (PD) and non-PD penile curvature. Topics include comments from Dr. Landon Trost, founder of the Male Fertility and Peyronie's Clinic in Orem, Utah, four subtypes of PD characterized by the investigators, and non-PD categorizations identified by the investigators.

The article discusses research published in the issue of the "Journal of Urology" which examined the efficacy of collagenase clostridium histolyticum (CCH) injections for treatment of Peyronie disease compared with surgery. Study results indicated less curvature improvement but greater penile length, change in penile sensation, higher patient satisfaction and fewer adverse outcomes in those who received CCH injections than those in the surgery group.

The article discusses several European studies conducted by Dr. Georgios Hatzichristodoulou on the use of shock wave therapy for erectile dysfunction and Peyronie's disease. Topics include the European Association of Urology guideline for erectile dysfunction, study finding on the most ideal candidates for shock wave therapy, and drawbacks of shock wave therapy. A YouTube video by Dr. Tobias Kohler about erectile dysfunction treatment scams is also mentioned.

The article discusses the take-home messages from the American Urological Association's annual meeting for 2018 that was held in San Francisco, California. Topics mentioned include prostate cancer treatment, lower urinary tract symptoms, the neoadjuvant treatment for muscle-invasive urothelial bladder carcinoma, and robotic inguinal lymph node dissection. Among the speakers include urologist Kelvin A. Moses and urologic surgeon Zephe Okeke.

An interview with three urologists on how they handle patients who ask them about medical information that they know is wrong. Kevin Krughoff cites useful resources for medical information while Jonathan Block talks about the problem caused by patients not trusting physicians as much as they used to, and Bradley Bell explains the role of urologists in helping patients identify health misinformation.

The article discusses a retrospective study, which has found that depression is common among individuals with Peyronie disease (PD). Topics covered include factors that could predict depression among individuals seeking evaluation for early PD, the direct impact of PD on mental health, and the characteristics that might help clinicians identify men with PD who are experiencing depression.

The article presents highlights from the 2021 Sexual Medicine Society of North America (SMSNA) Fall Scientific meeting on October 21 to 24, 2021 in Scottsdale, Arizona. Highlights include role of body mass index (BMI) when selecting dosage of testosterone enanthate, feasibility of platelet-rich plasma injections for Peyronie disease, and diabetes mellitus (DM) as predictive of lower erectile functional recovery (EFR) at two years post radical prostatectomy.

The article discusses research being done on sexual dysfunction. It references the study "Safety and efficacy of collagenase clostridium histolyticum in the treatment of acute phase Peyronie's disease: a multi-institutional analysis," by H.M.T. Nguyen, A. Yousif, A. Chung, et al., which was published online on August 27, 2020 in "Urology."

The article discusses a study published in the "Journal of Sexual Medicine" which compared Peyroni's disease patients who were treated with the RestoreX traction device, CCH, or the surgical options plication or incision and grafting at Mayo Clinic, Rochester, New York. Findings include the overall success rate of surgery, ideal procedure for each patient according to study author and urologist Dr. Landon Trost, and standard of Dr. Trost for treating Peyronie's disease.

The article discusses research which investigated the use of RestoreX penile traction therapy (PTT) device in treating Peyronie's disease, conducted by Landon Trost and colleagues, presented at the 2019 American Urological Association (AUA) annual meeting in Chicago, Illinois. Topics explored include the recommended usage of the PTT device daily, the observed improvement in penile length and curvature after three months of treatment, and the safety and efficacy demonstrated by RestoreX.

The article discusses research which found an increased risk of developing psychiatric disorders, in men with Peyronie disease (PD). It references a study by Ralf Kuja-Halkola et al published in the "Journal of Urology." Topics covered include details on patient characteristics, the failure of urologists to assess the impact of PD on mental health formally, issues discussed in the accompanying editorial commentaries about the study that were simultaneously published in the journal.

The article reports on how ultrasound may help identify underlying cause of erectile dysfunction (ED). Topics mentioned include the use of penile Doppler sonography to differentiate between vascular and nonvascular causes of ED, the contribution of ultrasound to successfully diagnosing three vascular-related causes of ED, and the penile deformity caused by scar tissue that develops after repeated injury.

The authors describe their thought processes in treating patients with Peyronie's disease (PD). Topics discussed include the significance of home photographs in providing a baseline assessment of the severity of the deformity and erection quality, a diagram that shows PD evaluation and treatment algorithm, and a table that outlines graft types and common examples of grafts used in PD.

The article introduces several urologic devices and products including desmopressin acetate (NOCTIVA) emulsified microdose nasal spray from Avadel Pharmaceuticals plc, Restore X device traction therapy for the treatment of Peyronie's disease, and blue light cystoscopy with hexaminolevulinate hydro-chloride for surveillance cystoscopy of bladder cancer from Photocure ASA.

Boston -- Low testosterone levels could play a role in Peyronie's disease, according to results of a retrospective chart review. Men with low levels of free testosterone had more severe [...]

The article focuses on the capability of implants to improve the sexual dysfunction of men with Peyronie's disease which will be discussed during the American Urological Association (AUA) annual meeting to be held in San Francisco, California. The use of penile implants have been viewed to attain an 80 to 90 percent overall satisfaction rate due to the enlargement of the erection. The surgery is done with the use of the prosthesis implantation.

The article reports on the findings of two studies regarding the post-surgical infection rates of patients with induratio penis plastica (IPP) in the U.S. According to Culley C. Carson, author of the first study, antibiotic-coated penile implants showed long-term efficacy in reducing the risk of infection. Brian Richardson, author of the second study, states that penile implants without antibiotics demonstrated reduced infection rates in short-term period.

The article discusses the study conducted by the urologists from Rush University Medical Center regarding the use of penile extender device in treating Peyronie's disease in Chicago, Illinois. The study administered to 10 men shows that the daily use of the device is safe and effective. The International Index of Erectile Function also reveals that the scheme can improve quality of life, as well as the erectile and sexual function.

The article discusses the study conducted to examine the efficacy of extracorporeal shockwave therapy in treating the disease pain of Peyronie. Georgios Hatzichristodoulou of the department of urology treated all patients with 2,000 shockwaves and the pains were assessed on a visual analog scale of one to ten. Primary findings of the study showed that 85 percent of the patients displayed improvement of pain compared to 48 percent of those patient in the placebo group.

The article analyzes the corporeal plication or plaque incision with venous grafting as a treatment for the Peyronie's disease. A study conducted at Kaiser Permanente Medical Center in Los Angeles, California revealed that there is no difference between the two methods regarding patient's satisfaction. The incision with graft mode was performed on 24 patients and the plication was performed on 18 patients.

The article presents a study which was conducted by Gerhald H. Jordan and his colleagues about the Peyronie's disease. The study found that small intestinal submucosal (SIS) results are same with the dermal graft for the disease. It has been found that 34 out of 43 surgical procedures using the dermal graft and 13 of 15 procedures using the SIS graft were considered successful.

The article reports on the findings of a study from the University of California-San Francisco about the usefulness of routine ultrasound in assessing flaccid penis in patients with Peyronie's disease. In the study, 24% of ultrasound images of the flaccid penis showed plaques that were not evident on palpation. The following abnormalities were detected by ultrasound: extensive calcification, septal defect calcification and corporal fibrosis.

Focuses on preferred surgical approaches of using tunica albuginea plication and plaque incision with pericardial grafting in the surgical treatment of Peyronie's disease. Goals for surgical reconstruction; Type of incision for the surgery.

Examines the use of cadaveric pericardium as grafting material following peyronie disease plaque excision in Anaheim, California. Factors affecting the success of grafting; Correction of curvature significant for normal sexual function; Placement of penile prostheses secondary to erectile dysfunction.

Focuses on the use of intralesional injection of the calcium channel blocker verapamil for the treatment of Peyronie's disease in the United States. Suitability of the technique for patients not psychologically ready or interested in surgery; Efficacy of the process in decreasing penile curvature; Possible complications.

Highlights improvements of surgical treatment procedures for Peyronie's disease in the United States. Success rate in correcting penile curvature; Surgical time; Success of erection following the procedure; Tips to ensure success of the procedure; Mechanics of venous patch grafting with a section of saphenous vein; Modified corporoplasty technique.

Presents information a study regarding corporoplasty surgery in patients with Peyronie's disease. Details on the study; Result of the study; Procedure of the surgical technique. INSET: Medical tx for Peyronie's effective only in early stage....

The article reports on the importance of formulating universal guidelines for the infection control strategies of patients with induratio penis plastica (IPP) in the U.S. According to Jason Greenfield, assistant professor of clinical urology at Columbia University, the protocol of surgeons in the treatment of IPP with penile implants differ widely. It presents the findings of the survey conducted by Greenfield regarding the use of antibiotics for the post-surgical treatment of IPP.

The article discusses a study which found that noninvasive vacuum protocol can prevent penile shortening in erectile dysfunction patients using an inflatable penile prosthesis. The study revealed that the original length of penis can be restored through this protocol. Moreover, the study suggested that patients suffering from Peyronie's disease should use a vacuum device a twice a day prior to the scheduled procedure.

The article reports the results of a survey which investigates urologists' knowledge on Peyronie's disease (PD) and their practice patterns in the U.S. It revealed that large portion of the respondents considered themselves experts in sexual medicine. However, it also indicated that many of them have shown gaps in basic knowledge and most see few patients per month.

The article reports on the survey conducted by the urologists at Weill Cornell Medical College, which found significant gaps in respondents' understanding of Peyronie's disease therapy. Of the surveyed, 72% said they used oral agents as first-line treatment and 5% used transdermal agents. According to John J. Mulchahy, clinical professor of urology at the University of Arizona with radial prostatectomy, erectile dysfunction appears immediately, with brachtherapy takes longer to develop.

The article focuses on the misconceptions about the origin of Peyronie's disease. According to Dr. John Mulcahy, a private practice urologist in Phoenix, Arizona, these fallacies about Peyronie's disease can lead to therapeutic strategies that have little or no chance of succeeding. This disease is characterized by abnormal curvature of the penis, resulting from the formation of plaque-like scar tissue.

The article reports on the development of various studies for the treatment of male sexual dysfunction. Dapoxetine, a selective serotonin reuptake inhibitor, has been studied and has demonstrated efficacy in the treatment of premature ejaculation. Moreover, it was found out that surgical reconstruction does not increase the risk of erectile dysfunction in men with Peyronie's disease. It was observed that patient satisfaction is strongly associated with penile length and erectile dysfunction.

The article focuses on a study involving the use of xenografts for treating Peyronie's disease. The study was conducted by surgeons at the Mayo Clinic in Jacksonville, Florida. They found that the graft material Surgisis worked better than the graft material Tutoplast. Surgisis is manufactured by Cook Biotech Inc. Urologist Raymond W. Pak says that the disease is associated with penile shortening.

Discusses the findings of a research by John P. Mulhall and colleagues in New York about the effectiveness of intralesional verapamil in stabilizing Peyronie's disease. Lower rate of deformity progression in patients treated with intralesional verapamil; Improvement in penile curvature; Resolution of pain.

Discusses the findings of a clinical research by Muammer Kendirci and colleagues in Louisiana about the effectiveness of intralesional interferon in patients with Peyronie's disease. Improvement in penile curvature and blood flow; Safety and interferon alpha-2b; Resolution of pain.

Reports on the potential of intralesional interferon alpha2b (Intron-A) for the treatment of men with Peyronie's disease with or without erectile dysfunction. Percentage of men who have achieved significant improvement in penile curvature; Indication of Intron-A; Evaluation of the plaque and curvature of patients previously treated for Peyronie's disease.

Discusses the study conducted by researchers from the University of Connecticut revealing that some patients with Peyronie's disease have sensory deficits prior to treatment. Highlights of preliminary findings; Results of the literature search conducted by the researchers; Use of biothesiometry in the study,

Investigates patient satisfaction with plaque incision and vein grafting for Peyronie's disease. Data showing that most patients are unsatisfied with the results five years postoperatively due to unmet expectations.

Discusses results of research studies on the efficacy and safety of verapamil gel for the treatment of Peyronie's disease. Improvement in the conditions of patients who participated in the study; Superiority of topical verapamil over other drugs in improving curvature and improving erection quality; Inability of the drug to be readily absorbed into the tunica albuginea.

Contains summaries of articles of interest to urologists from published consumer magazines, Web sites and news sources. Prostate cancer preventing potential of red wine; Injectable drug to treat men with Peyronie's disease.

Reports the advantages of cadaveric pericardial tissue graft for the treatment of Peyronie's disease in Anaheim, California. Reduction of tissue preparation time; Comparison of pericardial tissue and tunica albuginea; Surgical treatment of the disease.

Reports the efficacy of small intestine submucosa (SIS) grafts in preserving erectile responses of patient's with Peyronie disease in Anaheim, California. Evidence on in vivo erectile response after implantation; Stimulation of a minimal inflammatory responses; Suitability of SIS as graft material in animal trial.

Reports the efficacy of invasive surgical technique to correct penile curvature of patients with Peyronie disease in Anaheim, California. Emphasis of the technique; Limitation of tunica albuginea destructions; Application of saline-induced erection for the confirmation of penile straightening.

Presents the treatment options for Peyronie diseases in the United States. Efficacy of sildenafil citrate for patients with curved and soft erection; Procedure standards to straighten the penis without an implant; Graft materials used in the penis straightening.

Focuses on surgical techniques for the treatment of Peyronie's disease in the United States. Use of dermal tissue and cadaveric pericardium; Details of the Horton-Devine procedures; Report of good penile straightness and erectile function after surgery; Advantages of cadaveric pericardium; Accounts on the surgical procedures.

Reports on the effectiveness of cadaveric pericardial tissue as replacement tissue in procedures to correct Peyronie's disease. Benefits of the technique used to treat patients with penile curvature; Availability of cadaveric pericardium in operations such as plastic surgery to urologic procedures such as placement of pubovaginal slings.

Reports on the importance of preoperative assessment to straighten patient's expectations when treating Peyronie's disease. Ultrasound to assess circulation; Therapies for potency problems; Aspects of the procedure essential to its success including venous graft; Neurovascular bundle.